EASIX for prediction of survival in lower-risk myelodysplastic syndromes
2019 · Blood Cancer Journal · 59 citations
https://doi.org/10.1038/s41408-019-0247-z
J
Jennifer Kaivers
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
45
Papers
555
Citations
11
h-index
13
i10-index
Jennifer Kaivers is an academic researcher from Essen University Hospital. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Hematopoietic Stem Cell Transplantation & Myeloproliferative Neoplasms: Diagnosis and Treatment. The author has an h-index of 11, co-authored 39 publications.
ORCID: 0000-0003-3255-721XPapers by this author
worksAllogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries
2024 · Leukemia · 16 citations
https://doi.org/10.1038/s41375-024-02186-x
Influence of platelet count at diagnosis and during the course of disease on prognosis in MDS patients
2021 · Annals of Hematology · 11 citations
https://doi.org/10.1007/s00277-021-04608-7
Analysis of the impact of adherence to guidelines and expert advice in patients with myelodysplastic syndromes
2020 · Annals of Hematology · 10 citations
https://doi.org/10.1007/s00277-020-04325-7
Allogeneic hematopoietic stem cell transplantation and pre-transplant strategies in patients with NPM1-mutated acute myeloid leukemia: a single center experience
2023 · Scientific Reports · 5 citations
https://doi.org/10.1038/s41598-023-38037-5
The IPSS-R has prognostic impact in untreated patients with MDS del(5q)
2018 · Leukemia Research · 4 citations
https://doi.org/10.1016/j.leukres.2018.07.019
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat